Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

Delayed Quote. Delayed  - 09/29 08:30:12 pm
41.61 USD   -1.61%
09/28 GLOBAL DRUG ELU : BOSTON SCIENTIFIC, JOHNSON and JOHNSON, ABBOTT LAB..
09/28 ABBOTT LABORATO : Receives FDA Approval for the FreeStyle Libre Pro&..
09/28 ABBOTT : Receives FDA Approval for the FreeStyle Libre Pro(TM) Syste..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies 
Strengths
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • The group usually releases upbeat results with huge surprise rates.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses

No significant weakness

Ratings chart
Subsector Pharmaceuticals - NEC
1st jan.Capitalisation (M$)Investor Rating
ABBOTT LABORATORIES-5.83%62 166
JOHNSON & JOHNSON16.23%326 636
ROCHE HOLDING LTD.-12.41%217 190
NOVARTIS AG-10.14%212 589
PFIZER INC.5.30%206 172
MERCK & CO., INC.19.84%175 038
GLAXOSMITHKLINE PLC20.54%105 036
SANOFI-13.08%98 872
ALLERGAN PLC-23.91%94 153
BRISTOL-MYERS SQUIBB CO-19.92%92 048
ELI LILLY AND CO-4.21%89 091
Autres valeurs du secteur
Company
Engages in the discovery, development, manufacture and sale of health care productsAbbott Laboratories engages in the discovery, development, manufacture and sale of a broad and diversified line of health care products.It operates through four reportable segments: Established Pharmaceutical... 
Sector
Pharmaceuticals
Calendar
10/12Ex-dividend day
More about the company
Advertisement
Financials ($)
Sales 2016 20 939 M
EBIT 2016 3 925 M
Net income 2016 2 235 M
Debt 2016 2 699 M
Yield 2016 2,45%
P/E ratio 2016 23,67
P/E ratio 2017 18,30
EV / Sales 2016 3,10x
EV / Sales 2017 2,96x
Capitalization 62 166 M
More Financials
Chart ABBOTT LABORATORIES
Duration : Period : Day
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | 4-Traders
Duration : Period : Week
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | 4-Traders
Surperformance© ratings  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
More Ratings